Seminars in Clinical Psychopharmacology (eBook, PDF)

Redaktion: Haddad, Peter M.

• Format: PDF

Produktbeschreibung

This greatly expanded third edition provides a comprehensive overview of clinical psychopharmacology, incorporating the major advances in the field since the previous edition's publication. Renowned experts from psychiatry, pharmacy, and nursing have integrated basic science, psychopharmacology, and clinical practice throughout the book in order to provide a thorough basis for prescribing. It covers all key psychiatric drugs and disorders and includes the latest data on efficacy, safety and tolerability. Adopting a pragmatic approach to drug nomenclature, both Neuroscience-based Nomenclature (NbN) and older generic terminology are included in the text reflecting that clinicians are likely to use both systems. Many chapters refer to current National Institute of Health and Care Excellence (NICE) guidelines, making this a crucial resource. Edited by leading authorities in the field, Professor Peter M. Haddad and Professor David J. Nutt, Seminars in Clinical Psychopharmacology emphasises evidence-based prescribing with the aim of achieving better clinical outcomes for patients.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 18. Juni 2020
• Englisch
• ISBN-13: 9781108851244
• Artikelnr.: 66183288

Inhaltsangabe

List of contributors; Foreword Peter Tyrer; Preface; Editor's note on
nomenclature; Neuroscience-based nomenclature glossary; List of
abbreviations; Part I. Basic Science and General Principles: 1. A brief
history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard
Green; 2. Psychiatric drug discovery and development Mohammed Shahid,
Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of
drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics
Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and
psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques
and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology
Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the
Main Psychotropic Drug Groups: 7. Drugs to treat depression Patrick
McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David
S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis
(dopamine antagonists and partial agonists other than clozapine) Robert
McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard
Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12.
Anticonvulsants for mental disorders: valproate, lamotrigine,
carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat
attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and
Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and
Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia
Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David
Christmas and Keith Matthews; Part III. Specific Therapeutic Areas: 17.
Drug treatment in childhood and adolescence David Coghill and Nicoletta
Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing
in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical
management of acute disturbance including rapid tranquilisation Faisil
Sethi, Caroline Parker, Aileen O'Brien and Maxine X. Patel; 21.
Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin
P. Reynolds; Index.